These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37439836)

  • 1. Placental fetal vascular malperfusion in congenital diaphragmatic hernia.
    Stanek J
    Virchows Arch; 2024 Jan; 484(1):83-91. PubMed ID: 37439836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of Histological Distal Villous Fetal Vascular Malperfusion in the Placenta: Clinical Significance and Placental Features.
    Stanek J
    Ann Clin Lab Sci; 2024 May; 54(3):289-298. PubMed ID: 39048170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental CD34 immunohistochemistry in fetal vascular malperfusion in stillbirth.
    Stanek J; Drach A
    J Obstet Gynaecol Res; 2022 Mar; 48(3):719-728. PubMed ID: 35092332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental recent/on-going foetal vascular malperfusion with endothelial fragmentation is diagnostically equivalent to established distal villous lesions of foetal vascular malperfusion.
    Stanek J
    Pol J Pathol; 2022; 73(3):198-207. PubMed ID: 36734434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34 immunostain increases sensitivity of the diagnosis of fetal vascular malperfusion in placentas from ex-utero intrapartum treatment.
    Stanek J
    J Perinat Med; 2021 Feb; 49(2):203-208. PubMed ID: 32903209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of the Large Fetal Vessel Lesions in Placental Fetal Vascular Malperfusion.
    Stanek J
    Lab Invest; 2024 Jul; 104(7):102089. PubMed ID: 38810837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 immunostain increases the sensitivity of placental examination for distal fetal vascular malperfusion in liveborn infants.
    Stanek J
    Placenta; 2023 Sep; 140():117-124. PubMed ID: 37573725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Umbilical Artery Umbilical Cord Is Associated With High-Grade Distal Fetal Vascular Malperfusion.
    Stanek J
    Pediatr Dev Pathol; 2024; 27(1):52-58. PubMed ID: 37771135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34 immunostain increases the sensitivity of placental diagnosis of fetal vascular malperfusion in stillbirth.
    Stanek J; Abdaljaleel M
    Placenta; 2019 Feb; 77():30-38. PubMed ID: 30827353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord compromise versus other clinical conditions predisposing to placental fetal vascular malperfusion.
    Stanek J
    Placenta; 2022 Sep; 127():8-11. PubMed ID: 35921763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal heterogeneity of placental segmental fetal vascular malperfusion: timing but not etiopathogenesis.
    Stanek J
    Virchows Arch; 2021 May; 478(5):905-914. PubMed ID: 32918597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal villous lesions are clinically more relevant than proximal large muscular vessel lesions of placental fetal vascular malperfusion.
    Stanek J
    Histol Histopathol; 2022 Apr; 37(4):365-372. PubMed ID: 34939657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segmental villous mineralization: A placental feature of fetal vascular malperfusion.
    Stanek J
    Placenta; 2019 Oct; 86():20-27. PubMed ID: 31358342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology.
    Stanek J
    Virchows Arch; 2016 Jun; 468(6):723-32. PubMed ID: 26983702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of placental injury in various types of fetal congenital heart disease.
    Stanek J
    J Perinat Med; 2023 Jun; 51(5):704-711. PubMed ID: 36573345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental delayed villous maturation is associated with fetal congenital heart disease.
    O'Hare CB; Mangin-Heimos KS; Gu H; Edmunds M; Bebbington M; Lee CK; He M; Ortinau CM
    Am J Obstet Gynecol; 2023 Feb; 228(2):231.e1-231.e11. PubMed ID: 35985515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental vascular malperfusion lesions in fetal congenital heart disease.
    Leon RL; Sharma K; Mir IN; Herrera CL; Brown SL; Spong CY; Chalak LF
    Am J Obstet Gynecol; 2022 Oct; 227(4):620.e1-620.e8. PubMed ID: 35609643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns.
    Redline RW; Ariel I; Baergen RN; Desa DJ; Kraus FT; Roberts DJ; Sander CM
    Pediatr Dev Pathol; 2004; 7(5):443-52. PubMed ID: 15547768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between fetal vascular malperfusion and gestational diabetes.
    Goto T; Sato Y; Kodama Y; Tomimori K; Sameshima H; Aman M; Maekawa K; Yamashita A; Asada Y
    J Obstet Gynaecol Res; 2022 Jan; 48(1):80-86. PubMed ID: 34729872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal Vascular Malperfusion Due To Long and Hypercoiled Umbilical Cords Resulting in Recurrent Second Trimester Pregnancy Loss: A Case Series and Literature Review.
    Slack JC; Boyd TK
    Pediatr Dev Pathol; 2021; 24(1):12-18. PubMed ID: 32986509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.